Precautions for the Administration of Ixazomib

Release date: 2026-01-08 10:10:03     Recommended: 233

Ixazomib has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory multiple myeloma.

Precautions for the Administration of Ixazomib

Immediately inform your doctor if you experience burning, numbness, tingling, or pain in your arms, hands, legs, or feet. These could be symptoms of peripheral neuropathy.

This product may cause fluid retention (edema) in some patients. Promptly notify your doctor if you notice swelling of the face, arms, hands, lower legs, or feet, tingling sensations in hands or feet, or abnormal weight gain or loss.

Seek medical attention as soon as possible if you develop skin rash, erythema, or skin discoloration.

Thrombotic microangiopathy (damage to small blood vessels) may occur during the administration of this product. Immediately tell your doctor if you have symptoms such as fever, fatigue, confusion, visual impairment, or seizures.

Seek immediate medical care if you experience upper abdominal pain or tenderness, clay-colored stools, dark urine, anorexia, nausea, vomiting, or jaundice (yellowing of the eyes or skin). These may be symptoms of severe hepatic disorders.

Do not take other medications concurrently without your doctor’s approval, including prescription drugs, over-the-counter drugs, herbal preparations (e.g., St. John’s Wort), or vitamin supplements.

Storage and Disposal Conditions for Ixazomib

1. Store at room temperature, not exceeding 30°C (86°F).

2. Do not freeze.

3. Keep the capsules in the original packaging until immediately prior to administration.

4. Avoid direct contact with the contents of the capsules. If a capsule is damaged, do not allow the drug to come into direct contact with skin or eyes.

5. In case of skin contact, wash the affected area thoroughly with soap and water.

6. In case of eye contact, rinse the eyes thoroughly with clean water.

7. Dispose of any unused medication or waste materials in accordance with local regulations.

Information to Disclose to the Medical Team Before Taking Ixazomib

Inform your healthcare provider if you have any of the following conditions:

1. Renal disease.

2. Hepatic disease.

3. A history of abnormal or allergic reactions to ixazomib, other medications, foods, dyes, or preservatives.

4. Are pregnant or planning to become pregnant.

5. Are breastfeeding.